Elliott Richelson

The research of Elliott Richelson, M.D., and his group is focused on drug discovery in the area of neuropsychiatric diseases. These diseases include schizophrenia, Parkinson's disease, pain (including neuropathic pain), depression and attention deficit disorder. All research currently is preclinical and uses animal models.